3A, DPP4 activity was significantly increased in STZ-diabetic mice, whereas DPP4 activity was significantly inhibited by the treatment with sitagliptin (Fig
READ MORE - #GeneTherapy #CellTherapy #Type1Diabetes #BiotechInnovation To view or add a comment, sign in An article from Chemical & Engineering News highlights emerging research showing that gene-modified pancreatic cells may offer a new path toward treating type 1 diabetes
Shielding against environmental stressors, it counters premature aging, inflammation, and health woes
Telomere protection is well established
Implications for telehealth brands: Even if the FDA shuts down GLP-1 compounding, gray-market manufacturers and marketers will persist, blurring the lines between legitimate products and unauthorized alternatives
It can also be useful for those who have had side effects with the injectable form